WGTMM: WGAN with Transformer Feature Matching for Generating fMRI Data in MCI Patients.

backgroundThe emergence of generative adversarial networks has laid the groundwork for data augmentation, addressing challenges of missing training data in various research scenarios. However, simulating functional magnetic resonance imaging (fMRI) data remains particularly challenging, especially for populations with varying degrees of mild cognitive impairment (MCI). Effectively characterizing and capturing the mechanisms of brain function variations poses a critical issue in cognitive neuroscience. This study aims to simulate and analyze synthetic fMRI blood-oxygen-level-dependent (BOLD) signals across four cognitive stages: healthy control (HC), early MCI (EMCI), late MCI (LMCI), and Alzheimer's disease (AD).

methodsWe propose WGTMM, an innovative method that integrates the Vision Transformer for fMRI (VTFF) into a generative adversarial network architecture. Crucially, WGTMM directly generates fMRI time-series data from pink noise rather than modeling in a latent space, thereby preserving rich temporal dynamics. The framework incorporates a Wasserstein GAN (WGAN) with feature matching to enhance generation quality and mitigate mode collapse.

resultsdemonstrate that WGTMM-generated fMRI data exhibit lower Kullback-Leibler (KL) divergence compared to traditional GAN and WGAN models, indicating a closer resemblance to real datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Furthermore, when applied to data augmentation, the synthetic data substantially improve multi-class classification performance.

conclusionsWGTMM not only enriches training datasets but also provides new insights into spatial biomarkers of cognitive decline. By leveraging VTFF to investigate class token attention patterns across 360 brain regions, this study reveals monotonic weight variations along disease stages in key cortical areas, including the rostral Area 6, the primary sensory cortex, and PFm near Wernicke's area, offering a fine-grained exploration of disease progression.